- Report
- December 2025
- 192 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- May 2025
- 243 Pages
Global
From €2203EUR$2,500USD£1,935GBP
- Report
- December 2025
- 194 Pages
Global
From €5155EUR$5,850USD£4,528GBP
- Report
- April 2025
- 250 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- April 2025
- 400 Pages
Global
From €3957EUR$4,490USD£3,475GBP
- Report
- October 2025
- 160 Pages
Global
From €2959EUR$3,358USD£2,599GBP
€3481EUR$3,950USD£3,057GBP
- Report
- September 2021
- 589 Pages
Global
From €5287EUR$6,000USD£4,644GBP
- Report
- October 2022
- 137 Pages
From €3040EUR$3,450USD£2,670GBP
- Report
- October 2022
- 157 Pages
Asia Pacific
From €3040EUR$3,450USD£2,670GBP
- Report
- December 2024
- 123 Pages
Global
From €4402EUR$4,995USD£3,866GBP
- Report
- December 2024
- 1121 Pages
Global
From €8808EUR$9,995USD£7,736GBP
- Report
- April 2024
- 537 Pages
United States
From €7045EUR$7,995USD£6,188GBP
- Report
- February 2024
- 98 Pages
Global
From €3500EUR$4,255USD£3,182GBP
- Report
- January 2025
- 132 Pages
Global
From €837EUR$950USD£735GBP

The Bph Treatment Device market is a segment of the Medical Devices industry that focuses on the treatment of benign prostatic hyperplasia (BPH). BPH is a condition that affects the prostate gland, causing it to become enlarged and cause urinary symptoms. BPH Treatment Devices are used to reduce the size of the prostate and improve urinary symptoms. These devices include transurethral resection of the prostate (TURP), transurethral microwave thermotherapy (TUMT), and transurethral needle ablation (TUNA). These devices are minimally invasive and can be used to treat BPH without the need for surgery.
The Bph Treatment Device market is highly competitive, with a number of companies offering a variety of products. Some of the major players in the market include Boston Scientific, Medtronic, Olympus, and Cook Medical. Show Less Read more